Lee Financial CO Insulet Corp Transaction History

Lee Financial CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$186.4 - $279.02 $4,660 - $6,975	25 New	25 $5,000
Q4 2020 Feb 12, 2021	SELL	$215.97 - $265.89 $11,662 - $14,358	-54 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$159.17 - $224.73 $955 - $1,348	-6 Reduced 10.0%	54 $10,000
Q1 2020 May 07, 2020	BUY	$130.01 - $216.44 $1,300 - $2,164	10 Added 20.0%	60 $10,000
Q1 2019 Apr 30, 2019	BUY	$72.44 - $101.87 $3,622 - $5,093	50 New	50 $5,000

730

63.2M

630K

854K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.8B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.